Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

Oculis (OCS) announced the publication of a notification related to a managers' transaction on June 9, 2026 in Zug, Switzerland.

Rhea-AI Summary

Oculis (OCS) announced the publication of a notification related to a managers' transaction on June 9, 2026 in Zug, Switzerland.

The attached notification concerns the purchase of ordinary shares by a member of the company’s Executive Committee and Board of Directors.

Argus Jun 9 session

+2.52% close to close Open Argus

Details

News Market Reaction – OCS

On Jun 9, the day this news came out, OCS closed 2.52% above the previous close.

Data tracked by StockTitan Argus for the Jun 9 session.

Historical Context

5 past events · Latest: Jun 08

5 events

1. Jun 08

   Conference participation

   24h Move

   -3.1%

   Announcement of participation in Goldman Sachs healthcare conference and asset discussion.

2. May 29

   Manager RSU vesting

   24h Move

   -36.1%

   Notification of RSU vesting and settlement for a company director.

3. May 29

   Phase 3 trial results

   24h Move

   -23.4%

   OCS-01 diabetic macular edema Phase 3 trials failed primary and key secondary endpoints.

4. May 28

   Manager RSU vesting

   24h Move

   -23.4%

   Notification of RSU vesting and settlement for director Arshad Khanani.

5. May 15

   Director equity awards

   24h Move

   -7.3%

   Notifications on RSU vesting, annual director equity awards, and a one-time board grant.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

persons discharging managerial responsibilities

1 terms

persons discharging managerial responsibilities regulatory

"Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities"

Persons Discharging Managerial Responsibilities are the key people in a company who make big decisions, like top managers or executives. Knowing who they are is important because their actions can influence the company’s success or failure, and they are often required to share information about their dealings to ensure transparency for investors and the public.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ZUG, Switzerland, June 09, 2026 (GLOBE NEWSWIRE) -- The attached notification relates to the purchase of ordinary shares by a member of the Company’s Executive Committee and Board of Directors.

Attachment

• notification-of-managers-transaction-riad sherif-9-june-2026

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Oculis (OCS) disclose on June 9, 2026 about managerial transactions?

Oculis disclosed a notification related to a managers’ transaction involving ordinary share purchases. According to Oculis, the attached document details a transaction completed by a person who is both a member of the Executive Committee and the Board of Directors.

Who is involved in the Oculis (OCS) managers’ share purchase disclosed on June 9, 2026?

The disclosed transaction involves a member of Oculis’ Executive Committee and Board of Directors. The attachment title references “notification-of-managers-transaction-riad sherif-9-june-2026,” indicating the notification relates to a transaction associated with Riad Sherif’s managerial role.

What type of securities were purchased in the Oculis (OCS) managers’ transaction announced June 9, 2026?

The managers’ transaction notification relates to the purchase of Oculis ordinary shares. According to Oculis, the attached document specifically concerns ordinary share purchases by an individual serving on both the Executive Committee and the Board of Directors.

Where can investors find details of the June 9, 2026 Oculis (OCS) managers’ transaction?

Investors can review details in the attached managers’ transaction notification referenced in the announcement. Oculis points to a document titled “notification-of-managers-transaction-riad sherif-9-june-2026,” which is intended to provide specifics of the ordinary share purchase.

Does the June 9, 2026 Oculis (OCS) announcement mention changes to earnings or guidance?

The June 9, 2026 announcement does not mention earnings, revenue, or guidance changes. It is limited to noting a published notification about the purchase of ordinary shares by a member of the Executive Committee and Board of Directors.